Platform Expansion & Surgeon Education
Broader Soft Tissue Reconstruction
Key Facts
About TELA Bio
TELA Bio is a commercial-stage medical device company with a mission to address gaps in soft-tissue surgical innovation by prioritizing the preservation of native anatomy. Its primary achievement is the development and U.S./European commercialization of the OviTex Reinforced Tissue Matrix, a hybrid biologic-synthetic platform that represents a significant shift away from traditional, heavy-weight permanent mesh. The company's strategy is to capitalize on the growing market trend toward biologic and hybrid solutions in hernia repair and reconstructive surgery by demonstrating superior clinical and economic value. TELA Bio aims to expand its product portfolio and market penetration by leveraging its specialized commercial team and surgeon education initiatives.
View full company profile